PL3018147T3 - Siarczanowany polisacharyd poli(kwasu gulonowego) lub jego sól farmaceutyczna, sposób ich wytwarzania i ich zastosowanie - Google Patents
Siarczanowany polisacharyd poli(kwasu gulonowego) lub jego sól farmaceutyczna, sposób ich wytwarzania i ich zastosowanieInfo
- Publication number
- PL3018147T3 PL3018147T3 PL14819337T PL14819337T PL3018147T3 PL 3018147 T3 PL3018147 T3 PL 3018147T3 PL 14819337 T PL14819337 T PL 14819337T PL 14819337 T PL14819337 T PL 14819337T PL 3018147 T3 PL3018147 T3 PL 3018147T3
- Authority
- PL
- Poland
- Prior art keywords
- preparation
- method therefor
- pharmaceutical salt
- acid polysaccharide
- polygulonic acid
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
- A61K31/737—Sulfated polysaccharides, e.g. chondroitin sulfate, dermatan sulfate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/18—Drugs for disorders of the alimentary tract or the digestive system for pancreatic disorders, e.g. pancreatic enzymes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/08—Drugs for disorders of the urinary system of the prostate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/04—Antineoplastic agents specific for metastasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
- C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
- C08B37/006—Heteroglycans, i.e. polysaccharides having more than one sugar residue in the main chain in either alternating or less regular sequence; Gellans; Succinoglycans; Arabinogalactans; Tragacanth or gum tragacanth or traganth from Astragalus; Gum Karaya from Sterculia urens; Gum Ghatti from Anogeissus latifolia; Derivatives thereof
- C08B37/0084—Guluromannuronans, e.g. alginic acid, i.e. D-mannuronic acid and D-guluronic acid units linked with alternating alpha- and beta-1,4-glycosidic bonds; Derivatives thereof, e.g. alginates
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08L—COMPOSITIONS OF MACROMOLECULAR COMPOUNDS
- C08L5/00—Compositions of polysaccharides or of their derivatives not provided for in groups C08L1/00 or C08L3/00
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Engineering & Computer Science (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Polymers & Plastics (AREA)
- Molecular Biology (AREA)
- Dermatology (AREA)
- Biochemistry (AREA)
- Materials Engineering (AREA)
- Epidemiology (AREA)
- Urology & Nephrology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Gastroenterology & Hepatology (AREA)
- Endocrinology (AREA)
- Reproductive Health (AREA)
- Biomedical Technology (AREA)
- Oncology (AREA)
- Pulmonology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Polysaccharides And Polysaccharide Derivatives (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201310275323.7A CN104277130A (zh) | 2013-07-02 | 2013-07-02 | 一种硫酸酯化聚古洛糖酸多糖或其可药用盐及其制备方法和用途 |
EP14819337.8A EP3018147B1 (en) | 2013-07-02 | 2014-07-02 | Sulfated polygulonic acid polysaccharide or pharmaceutical salt thereof, preparation method therefor and use thereof |
PCT/CN2014/081472 WO2015000411A1 (zh) | 2013-07-02 | 2014-07-02 | 一种硫酸酯化聚古洛糖酸多糖或其可药用盐及其制备方法和用途 |
Publications (1)
Publication Number | Publication Date |
---|---|
PL3018147T3 true PL3018147T3 (pl) | 2018-10-31 |
Family
ID=52143111
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PL14819337T PL3018147T3 (pl) | 2013-07-02 | 2014-07-02 | Siarczanowany polisacharyd poli(kwasu gulonowego) lub jego sól farmaceutyczna, sposób ich wytwarzania i ich zastosowanie |
Country Status (20)
Country | Link |
---|---|
US (1) | US10058566B2 (pl) |
EP (1) | EP3018147B1 (pl) |
JP (2) | JP6757249B2 (pl) |
KR (1) | KR102258569B1 (pl) |
CN (2) | CN104277130A (pl) |
AU (1) | AU2014286711B2 (pl) |
BR (1) | BR112015032849B1 (pl) |
CA (1) | CA2916749C (pl) |
DK (1) | DK3018147T3 (pl) |
EA (1) | EA028655B1 (pl) |
ES (1) | ES2674976T3 (pl) |
HK (1) | HK1220984A1 (pl) |
HU (1) | HUE038981T2 (pl) |
MX (1) | MX2016000043A (pl) |
PL (1) | PL3018147T3 (pl) |
PT (1) | PT3018147T (pl) |
SG (1) | SG11201510717SA (pl) |
TR (1) | TR201809674T4 (pl) |
WO (1) | WO2015000411A1 (pl) |
ZA (1) | ZA201509353B (pl) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN104277130A (zh) * | 2013-07-02 | 2015-01-14 | 中国科学院上海药物研究所 | 一种硫酸酯化聚古洛糖酸多糖或其可药用盐及其制备方法和用途 |
CN107904240A (zh) * | 2017-12-04 | 2018-04-13 | 辽东学院 | 一种抗肝癌细胞转移的抑制剂组合物 |
Family Cites Families (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE3228231A1 (de) * | 1982-07-28 | 1984-02-02 | Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V., 8000 München | Arzneimittel, calciummischsalze von polymeren, anionischen carbonsaeuren und/oder schwefelsaeureestern, verfahren zu ihrer herstellung und ihre verwendung |
JPH0625304A (ja) | 1992-07-06 | 1994-02-01 | Higeta Shoyu Co Ltd | ガラクトサミン重合体硫酸化物及び該物質を 含有する抗ウイルス剤 |
CN1132209A (zh) * | 1995-03-27 | 1996-10-02 | 青岛海洋大学 | 一种新药多聚甘露糖醛酸硫酸盐 |
GB2317182B (en) * | 1996-09-11 | 2000-11-01 | Johnson & Johnson Medical | Sulfated polysaccharides and uses thereof in medical treatment |
CN1473836A (zh) * | 2003-08-04 | 2004-02-11 | 中国海洋大学 | 还原端1位为羧基的古罗糖醛酸寡糖及其衍生物 |
CN1213071C (zh) | 2003-11-25 | 2005-08-03 | 中国海洋大学 | 一种古糖酯及其制备方法和应用 |
JP4897310B2 (ja) * | 2006-02-28 | 2012-03-14 | 理研食品株式会社 | L−グルロン酸金属塩又はd−マンヌロン酸金属塩の製造方法 |
JP2008027767A (ja) * | 2006-07-21 | 2008-02-07 | Aomori Prefecture | 固体高分子電解質膜及び燃料電池 |
CN101691410B (zh) * | 2009-09-18 | 2011-12-28 | 中国海洋大学 | 一种具有防治胰岛素抵抗作用的海洋寡糖铬配合物 |
NZ602249A (en) * | 2010-03-10 | 2014-10-31 | Inovobiologic Inc | Food comprising glucomannan, xanthan gum and alginate for the treatment of metabolic disorders |
CN102743409B (zh) * | 2012-06-18 | 2013-11-20 | 中国海洋大学 | 聚甘露糖醛酸丙酯硫酸盐在制备抗甲型h1n1流感病毒药物中的应用 |
CN104277130A (zh) * | 2013-07-02 | 2015-01-14 | 中国科学院上海药物研究所 | 一种硫酸酯化聚古洛糖酸多糖或其可药用盐及其制备方法和用途 |
-
2013
- 2013-07-02 CN CN201310275323.7A patent/CN104277130A/zh active Pending
-
2014
- 2014-07-02 HU HUE14819337A patent/HUE038981T2/hu unknown
- 2014-07-02 MX MX2016000043A patent/MX2016000043A/es active IP Right Grant
- 2014-07-02 BR BR112015032849-0A patent/BR112015032849B1/pt not_active IP Right Cessation
- 2014-07-02 WO PCT/CN2014/081472 patent/WO2015000411A1/zh active Application Filing
- 2014-07-02 AU AU2014286711A patent/AU2014286711B2/en not_active Ceased
- 2014-07-02 US US14/901,297 patent/US10058566B2/en not_active Expired - Fee Related
- 2014-07-02 KR KR1020167002769A patent/KR102258569B1/ko active IP Right Grant
- 2014-07-02 PL PL14819337T patent/PL3018147T3/pl unknown
- 2014-07-02 EA EA201690123A patent/EA028655B1/ru unknown
- 2014-07-02 CA CA2916749A patent/CA2916749C/en not_active Expired - Fee Related
- 2014-07-02 CN CN201480038171.1A patent/CN105358582B/zh not_active Expired - Fee Related
- 2014-07-02 EP EP14819337.8A patent/EP3018147B1/en not_active Not-in-force
- 2014-07-02 ES ES14819337.8T patent/ES2674976T3/es active Active
- 2014-07-02 PT PT148193378T patent/PT3018147T/pt unknown
- 2014-07-02 TR TR2018/09674T patent/TR201809674T4/tr unknown
- 2014-07-02 SG SG11201510717SA patent/SG11201510717SA/en unknown
- 2014-07-02 DK DK14819337.8T patent/DK3018147T3/en active
- 2014-07-02 JP JP2016522246A patent/JP6757249B2/ja not_active Expired - Fee Related
-
2015
- 2015-12-23 ZA ZA2015/09353A patent/ZA201509353B/en unknown
-
2016
- 2016-07-28 HK HK16109038.7A patent/HK1220984A1/zh not_active IP Right Cessation
-
2019
- 2019-02-22 JP JP2019030255A patent/JP6772318B2/ja not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
PT3018147T (pt) | 2018-07-17 |
EA201690123A1 (ru) | 2016-07-29 |
SG11201510717SA (en) | 2016-01-28 |
AU2014286711B2 (en) | 2018-05-10 |
EP3018147A4 (en) | 2017-04-05 |
US10058566B2 (en) | 2018-08-28 |
JP6757249B2 (ja) | 2020-09-16 |
HUE038981T2 (hu) | 2018-12-28 |
ES2674976T3 (es) | 2018-07-05 |
JP2016523301A (ja) | 2016-08-08 |
ZA201509353B (en) | 2017-08-30 |
US20160367591A1 (en) | 2016-12-22 |
KR102258569B1 (ko) | 2021-05-28 |
CA2916749C (en) | 2021-03-09 |
TR201809674T4 (tr) | 2018-07-23 |
JP6772318B2 (ja) | 2020-10-21 |
JP2019090056A (ja) | 2019-06-13 |
EP3018147A1 (en) | 2016-05-11 |
WO2015000411A1 (zh) | 2015-01-08 |
CN104277130A (zh) | 2015-01-14 |
MX2016000043A (es) | 2016-05-31 |
HK1220984A1 (zh) | 2017-05-19 |
CA2916749A1 (en) | 2015-01-08 |
CN105358582B (zh) | 2018-09-21 |
CN105358582A (zh) | 2016-02-24 |
EA028655B1 (ru) | 2017-12-29 |
AU2014286711A1 (en) | 2016-02-04 |
KR20160029817A (ko) | 2016-03-15 |
BR112015032849A2 (pt) | 2020-05-12 |
DK3018147T3 (en) | 2018-07-23 |
BR112015032849B1 (pt) | 2021-09-14 |
EP3018147B1 (en) | 2018-05-23 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HK1212980A1 (zh) | 吡啶酮類衍生物、其製備方法及其在醫藥上的應用 | |
EP2815746A4 (en) | SAPONIN NANOMIZELES, MANUFACTURING METHOD, APPLICATION THEREOF AND PHARMACEUTICAL COMPOSITION THEREOF | |
HK1205118A1 (zh) | 環烷基甲酸類衍生物、其製備方法及其在醫藥上的應用 | |
HK1222563A1 (zh) | 藥物組合物、製備及其用途 | |
PL3064498T3 (pl) | Pirazolopirymidon lub pochodne pirolotriazonu, sposób ich otrzymywania i ich zastosowania farmaceutyczne | |
PL3116514T3 (pl) | Koniugaty oligomeru kwasu hialuronowego lub jego soli, sposób ich wytwarzania i ich zastosowanie | |
HK1225993A1 (zh) | 糖胺聚糖的化合物、其製備方法及用途 | |
EP3037099A4 (en) | Pharmaceutical composition, preparation method therefor and use thereof | |
IL243227A0 (en) | History of diaminocyclopentane carboxamide, their preparation and pharmaceutical preparations containing them | |
EP2941418A4 (en) | N1-CYCLIC AMIN-N5 SUBSTITUTED BIGUANIDE DERIVATIVES, METHOD FOR THE PREPARATION THEREOF AND PHARMACEUTICAL COMPOSITION THEREWITH | |
HK1206329A1 (en) | Phenol derivative, method of preparing same, and pharmaceutical application of same | |
EP2952519A4 (en) | PROTOPANOXADIOL DERIVATIVE, PREPARATION METHOD AND APPLICATION THEREOF | |
EP3078659A4 (en) | 3-FURYL-2-CYANO-2-ACRYLAMIDE DERIVATIVE, PROCESS FOR PREPARING THE SAME, PHARMACEUTICAL COMPOSITION AND USE THEREOF | |
HK1215863A1 (zh) | 光交聯的透明質酸衍生物及其製備方法和應用 | |
HK1220984A1 (zh) | 種硫酸酯化聚古洛糖酸多糖或其可藥用鹽及其製備方法和用途 | |
HK1244814A1 (zh) | 一種薯蕷皂苷元-3-位衍生物及其製備方法和用途 | |
IL240447A0 (en) | Propionic-biaryl acid derivatives and their use as pharmaceutical preparations | |
EP3050895A4 (en) | Salt of polypeptide vaccine, preparation method therefor, and pharmaceutical preparation comprising said salt | |
IL284405A (en) | Pharmaceutical composition, preparation and uses thereof | |
IL240422B (en) | Bi-aryl derivatives of propionic acid and their use as medicinal preparations |